Cyclosporin soft capsule composition

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424451, 424455, 424456, 514784, 514785, 514786, 514937, 514962, 514970, 514975, 514885, 514 11, A61K 910, A61K 948, A61K 3813

Patent

active

056394748

ABSTRACT:
The present invention relates to a microemulsion concentrate containing cyclosporin as an active ingredient, dimethylisosorbide as a cosurfactant, oil and a surfactant which is suitable for the formulation of a soft capsule for oral administration, said cyclosporin, dimethyl isosorbide, oil and surfactant being present in the ratio of 1:1-5:1-5:2-10, and preferably in the ratio of 1:2-4:2-5:2-4:7, by weight. Since dimethylisosorbide has substantially no membrane permeation property, the soft capsule preparation according to the present invention is outstandingly stable in comparison with the soft capsules containing ethanol, propylene glycol, transcutol, glycofurol, etc., as a cosurfactant in the prior art, and further provides an advantage in that the pharmaceutical effect, appearance and composition content of the soft capsule according to the present invention are not changed.

REFERENCES:
patent: 5589455 (1996-12-01), Woo

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclosporin soft capsule composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin soft capsule composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin soft capsule composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2156018

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.